Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer20 Nov ETF NVBW Stock Holding History
Bought
Maintained
Sold
Other funds holding NVBW
AAM
KAS
CRWM
SWM
JSA
FFA
PA
FFN
IA
Cambridge Investment Research Advisors's NVBW Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its AllianzIM U.S. Equity Buffer20 Nov ETF (NVBW) stake by 51% in Q2 2026, selling an estimated $1.38M and leaving 38,248 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2009.
Cambridge Investment Research Advisors first reported a position in NVBW in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.59M in Q1 2026. 23 funds tracked by Wall St. Rank hold NVBW as of Q2 2026.
- Cambridge Investment Research Advisors held 38,248 shares of AllianzIM U.S. Equity Buffer20 Nov ETF worth $1.36M as of Q2 2026.
- Cambridge Investment Research Advisors sold 39,444 AllianzIM U.S. Equity Buffer20 Nov ETF shares in Q2 2026, an estimated $1.38M.
- AllianzIM U.S. Equity Buffer20 Nov ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2009 holding.
- Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer20 Nov ETF in Q4 2022 and has held it in 15 quarters since.
- Cambridge Investment Research Advisors's AllianzIM U.S. Equity Buffer20 Nov ETF position peaked at $2.59M in Q1 2026.
- 23 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer20 Nov ETF as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.